[Early diagnosis of phlebothromboses of the leg with the radiofibrinogen test in patients with alloplastic hip joint replacement (author's transl)].
Explore the source record for details and available documents.
Fibrinogen↗
Biomedical subjects
M Barthels
Publications and source records attributed to M Barthels.
[The problem of activation of the coagulation system in preserved blood].
Explore the source record for details and available documents.
Blood Coagulation↗
[Methods and clinical value of fibrinogen determination using Laurell's quantitative immunoelectrophoresis].
Explore the source record for details and available documents.
Buffers↗
[Diagnostic studies in congenital afibrinogenemia].
Explore the source record for details and available documents.
Afibrinogenemia↗
[The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
Explore the source record for details and available documents.
Adult↗
[Early diagnosis of thrombosis using labeled fibrinogen after alloplastic hip-joint prosthesis].
Explore the source record for details and available documents.
Adult↗
[Pseudofibrinolysis in the thrombelastogram, factor XIII and fibrinogen split products in the 2nd half of normal pregnancy, during labor, and puerperium (author's transl)].
Explore the source record for details and available documents.
Factor V↗
Substitution of lipids with bile salts in the formation of thrombin.
Explore the source record for details and available documents.
Animals↗
[Comparative studies of blood coagulation factors in various sections of the circulatory system in children with congenital heart defects].
Explore the source record for details and available documents.
Blood Coagulation Factors↗
Concentrations of phenprocoumon in serum and serum water determined by high-performance liquid chromatography in patients on oral anticoagulant therapy.
Two convenient high-performance liquid chromatography procedures are proposed for the determination of phenprocoumon (Marcumar) in serum (S-PPC) and its unbound fraction in serum water (SW-PPC). S-PPC and SW-PPC were determined in samples from 53 patients undergoing oral anticoagulant therapy who were within the therapeutic interval of the thrombotest. S-PPC concentrations ranged from 0.6 to 5.0 mg/l, SW-PPC from 1.4 to 21.1 micrograms/l. A linear correlation (r = 0.714) was found between S-PPC and SW-PPC concentrations in the patient samples, the mean free fraction being 0.30%. S-PPC and SW-PPC concentrations were intra-individually stable during therapy. A linear correlation (r = 0.710) was observed between S-PPC concentrations and dosage.
Administration, Oral↗